UNAVETS acquires Diagnosfera, a leading referral specialty centre based in Madrid. Pedro Esteve, Diagnosfera’s Technical Director, leads the area of cardiology, thoracic and vascular surgery, ultrasound and minimally invasive techniques. The rest of the veterinary medical team specialists are responsible for the advanced areas of oncology, neurology, surgery, internal medicine, feline medicine, diagnostic imaging and minimally invasive techniques.
The referral clinic has a special expertise and focus on cardiology and interventions, valvuloplasties, pacemakers, Amplatzer and Holter.
The center also has a Brachycephalic Syndrome Unit, using Ultrasound Scalpel and the well-known telemedicine and remote diagnosis service for ECG, radiology, Cardiosonic remote CT interpretation, with a strong referral base from Spanish clinics.
Pedro Esteve, Technical Director of Diagnosfera comments: “Joining UNAVETS means joining a project with confidence and prestige, with the challenge of contributing the best of ourselves to the rest of the group, knowing that Diagnosfera and UNAVETS are committed to training and offering high standards of medicine, with the objective of continuing to grow in specialization and services at the service of the referring veterinary clinics that place their trust in us.”
The UNAVETS team believes Diagnosfera will provide a unique specialty expertise to the group. José Ramón Escribano, senior advisor to the group, says “We continue to invest in innovative and highly credible healthcare expertise and focus on the fundamentals of veterinary healthcare.”
With this new addition, UNAVETS now has a total of 35 veterinary centers, 16 in Spain and 19 in Portugal, continuing its rapid expansion.
UNAVETS is a veterinary group that has about 345 professionals in Spain and Portugal. The clinical team members of more than 315 vets, nurses, groomers and front desk reception staff are supported by more than 30 members of the finance, marketing, operations, IT and human resources team that provide shared business support to the clinical directors and clinical team members.
UNAVETS was financed in December 2019 with funds managed by Oaktree Capital Management L.P. (“Oaktree”). Oaktree is a leader among global investment managers specializing in alternative investments, with $140 billion in assets under management as of September 30, 2020. Oaktree’s European Principal strategy manages more than € 4.5 billion in assets under management.
